ISSN (Print): 2394-6555
ISSN (Online): 2394-2002
About the Journal
Audience | Review process | Editorial Team | About the Editors | Facts about the Journal | Benefits | Abstracting and Indexing Information | Journal Ethics | Plagiarism Policy | Archival Policy | Open Access Publication and Creative Commons Licensing | Ahead of Print Policy | Advertisements | Subscription Information | Publisher
The Drug Development and Therapeutics (DDT) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Drug synthesis and development and Therapeutics from industry, Clinicians and Academia. The journal is owned by the Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS) and published by the Scientific Scholar.
Our audience includes Drug Development and Therapeutics also including Natural products, Target validation, Targeted drug discovery, High-throughput screening, Combinatorial chemistry, and library design, Drug delivery, ADME/Tox, PK/PD, Pharmacology, Pharmaceutical formulation, Genomics and proteomics, molecular modeling, Bioinformatics, Vaccines, Clinical trial evaluations. Pharmaceutical sciences, medicinal/analytical sciences, Biotechnology, Bioallied Sciences.
The Drug Development and Therapeutics (DDT) has a highly rigorous double-blinded peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts of interest, affiliations and financial disclosures such that the published content is not biased.
In-house submissions that contain the work of any editorial board member, are not allowed to be reviewed by that editorial board member and all decisions regarding this manuscript are made by an independent editor. In addition, these manuscripts are reviewed by the two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.
The editorial board comprises a panel of experts in Drug synthesis and development and Therapeutics from industry, Clinicians and Academia from various countries to provide their expertise and guidance to the Editor-In-Chief in maintaining the clarity of content and focus of the journal’s purpose.
About the Editor
Raid Alany, PhD
Kingston University, London, UK
Hazrina Hadi, PhD
Faculty of Pharmacy,
International Islamic University of Malaysia,
Himanshu Gupta, M. Pharm, PGDIB, PhD
The University of Toledo,
Facts about the Journal
The Drug Development and Therapeutics (DDT) is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is quarterly. The Drug Development and Therapeutics (DDT) is published in E-Journal format and the journal is also available in print on demand.
A manuscript published in the Drug Development and Therapeutics (DDT) can be read and downloaded by readers all over the world without any charges or fees. The author retains the copyright of the manuscript and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.
Abstracting and Indexing Information
EBSCO Publishing Electronic Databases
The Drug Development and Therapeutics (DDT) is committed to meeting and upholding ethical guidelines at all stages of the publication process. We follow the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines Section.
We provide plagiarism check software (iThenticate) on the Editor’s and Reviewer’s panel in the manuscript management system. We encourage our editors and reviewers to use the plagiarism check. The manuscript’s found to have plagiarism is rejected.
Open Access Publication and Creative Commons Licensing
The Drug Development and Therapeutics (DDT) is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. The Drug Development and Therapeutics (DDT) has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place (https://scientificscholar.com/adv-policies/) to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “Banner” advertisement appears at a fixed location on the page and does not interfere with the reading/display of the manuscript in any form (https://ddtjournal.net/advertise/).
All advertisements are approved in consultation with Editor-In-Chief/the Editorial Board.
Advertisers submit their advertisements without prior information of the journal content to be published.
The Drug Development and Therapeutics (DDT) is a quarterly publication and published manuscripts in the journal can be read and downloaded by readers all over the world without any charges or fees.
The journal is published in E-Journal format and the journal is also available in print on demand. Journal also offers a Print-on-Demand subscription – https://scientificscholar.com/buy-subscriptions/.
Imaging Science Today was founded in 2011 by a group of practicing doctors and industry specialists, it changed its name to Scientific Scholar LLC, USA (scientificscholar.com). All the scientific journal publishing of Imaging Science Today was brought under the umbrella of Scientific Scholar LLC in 2017. Scientific Scholar LLC (scientificscholar.com) is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its peer-review management system – EditorialAssist (journalmanagement.org). The head office of Scientific Scholar (scientificscholar.com) is in Rochester, NY, USA and has a subsidiary arm in India.
Scientific Scholar (scientificscholar.com) owns its Manuscript Management System called EditorialAssist (journalmanagement.org). This system is very intuitive with a very short learning curve. The overall functionality of this system is based on “DRAG AND DROP”.
The mission of the Scientific Scholar (scientificscholar.com) is “Share, Learn and Improve”.
Scientific Scholar (scientificscholar.com) currently publishes many prestigious and indexed journals like the Journal of Clinical Imaging Science (clinicalimagingscience.org), Surgical Neurology International (surgicalneurologyint.com), CytoJournal (cytojournal.com) and many more (scientificscholar.com/journals). Scientific Scholar (scientificscholar.com) currently publishes approximately thirty three peer-reviewed journals.